Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy

被引：0
|
作者：
Marks, R. A.
Zhang, S. B.
Montironi, R.
McCarthy, R. P.
MacLennan, G. T.
Lopez-Beltran, A.
Jiang, Z.
Zhou, H. H.
Zheng, S. Q.
Davidson, D. D.
Baldridge, L. A.
Cheng, L.
机构：
[1] Indiana Univ, Indianapolis, IN USA
[2] Polytech Univ Marche Region, Ancona, Italy
[3] United Hosp, Ancona, Italy
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
[5] Univ Cordoba, E-14071 Cordoba, Spain
[6] Univ Massachusetts, Worcester, MA USA
[7] N China Coal Med Coll, Tangshan, Peoples R China
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
773
引用
收藏
页码：169A / 170A
页数：2
相关论文
共 50 条
  • [41] Pathophysiological basis for therapy targeted on epidermal growth factor receptor (EGFR) inhibition
    Wojtukiewicz, Marek Z.
    Sierko, Ewa
    Szambora, Pawel
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (05): : 217 - 227
  • [42] Expression of epidermal growth factor receptor (EGFR) in renal cell neoplasms.
    Shah, RV
    Gokden, N
    James, J
    Kota, M
    Kohli, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 886S - 886S
  • [43] Epidermal Growth Factor Receptor (EGFR) Expression in Vulvar Squamous Cell Carcinoma
    Liang, Li
    Villalobos, Pamela
    Lee, Chi Hyun
    Ning, Jing
    Mino, Barbara
    Wang, Wei-Lien
    Canales, Jaime Rodriguez
    Jazaeri, Amir A.
    Wistuba, Ignacio I.
    Yemelyanova, Anna
    LABORATORY INVESTIGATION, 2017, 97 : 297A - 297A
  • [44] EPIDERMAL GROWTH-FACTOR RECEPTOR CONTENT IN RAT PROSTATIC ADENOCARCINOMA - EFFECTS OF ENDOCRINE TREATMENT
    DAMBER, JE
    BERGH, A
    ASSARSSON, B
    GAFVELS, M
    UROLOGICAL RESEARCH, 1995, 23 (02): : 119 - 125
  • [45] Epidermal Growth Factor Receptor Expression in Esophageal Adenocarcinoma: Relationship with Tumor Stage and Survival after Esophagectomy
    Navarini, Daniel
    Gurski, Richard R.
    Madalosso, Carlos Augusto
    Aita, Lucas
    Meurer, Luise
    Fornari, Fernando
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [46] Molecular Heterogeneity of Compound Epidermal Growth Factor Receptor (EGFR) Mutations in Lung Adenocarcinoma (LAC)
    Brooks, R.
    Shiarli, A. M.
    Wang, H.
    ThippuJayaprakash, K.
    Liu, H.
    Gilligan, D.
    Hannon, C.
    Bulusu, R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S475 - S475
  • [47] Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma
    Frolov, Andrey
    Liles, J. Spencer
    Kossenkov, Andrew V.
    Tzeng, Ching-Wei D.
    Jhala, Nirag
    Kulesza, Peter
    Varadarajulu, Shyam
    Eloubeidi, Mohamad
    Heslin, Martin J.
    Arnoletti, J. Pablo
    AMERICAN JOURNAL OF SURGERY, 2010, 200 (03): : 398 - 405
  • [48] Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
    Wu, Shang-Gin
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Lee, Jih-Hsiang
    Hsu, Ya-Chieh
    Chang, Yih-Leong
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    LUNG CANCER, 2011, 72 (03) : 333 - 339
  • [49] Adequacy of biopsy samples for epidermal growth factor receptor (EGFR) molecular testing in lung adenocarcinoma
    Tegeltija, Dragana
    Lovrenski, Aleksandra
    Vasiljevic, Tijana
    Andrejic-Visnjic, Bojana
    VOJNOSANITETSKI PREGLED, 2021, 78 (04) : 435 - 439
  • [50] FDG uptake and epidermal growth factor receptor (EGFR) mutations in patients (pts) with lung adenocarcinoma
    Rensi, Marco
    Giacomuzzi, Francesco
    De Maglio, Giovanna
    Bonutti, Faustino
    Stanic, Davide
    Fasola, Gianpiero
    Pizzolitto, Stefano
    Geatti, Onelio
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
12345